NOVO, Giuseppina
 Distribuzione geografica
Continente #
NA - Nord America 22.570
EU - Europa 10.408
AS - Asia 3.561
AF - Africa 172
SA - Sud America 77
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 19
Totale 36.831
Nazione #
US - Stati Uniti d'America 22.523
IT - Italia 3.416
FI - Finlandia 1.782
CN - Cina 1.683
UA - Ucraina 1.502
SG - Singapore 1.426
DE - Germania 1.308
IE - Irlanda 640
GB - Regno Unito 450
SE - Svezia 305
RU - Federazione Russa 253
FR - Francia 177
RO - Romania 147
CI - Costa d'Avorio 143
IN - India 137
BE - Belgio 130
NL - Olanda 68
KR - Corea 67
HK - Hong Kong 62
CH - Svizzera 61
IR - Iran 61
BR - Brasile 56
PL - Polonia 38
CA - Canada 30
TR - Turchia 28
AT - Austria 24
CZ - Repubblica Ceca 21
ES - Italia 21
EG - Egitto 19
AU - Australia 18
GR - Grecia 15
EU - Europa 14
UZ - Uzbekistan 14
TW - Taiwan 11
JP - Giappone 10
CU - Cuba 8
LB - Libano 8
CL - Cile 7
MY - Malesia 7
PT - Portogallo 7
TH - Thailandia 7
AL - Albania 6
BG - Bulgaria 6
HR - Croazia 6
NZ - Nuova Zelanda 6
PH - Filippine 6
A2 - ???statistics.table.value.countryCode.A2??? 5
HU - Ungheria 5
ID - Indonesia 5
MX - Messico 5
LU - Lussemburgo 4
RS - Serbia 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
IL - Israele 3
LY - Libia 3
NO - Norvegia 3
PA - Panama 3
PE - Perù 3
VN - Vietnam 3
ZA - Sudafrica 3
AR - Argentina 2
BY - Bielorussia 2
CY - Cipro 2
DZ - Algeria 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
AM - Armenia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CO - Colombia 1
DK - Danimarca 1
IS - Islanda 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
MM - Myanmar 1
OM - Oman 1
PK - Pakistan 1
PR - Porto Rico 1
PY - Paraguay 1
QA - Qatar 1
SA - Arabia Saudita 1
SM - San Marino 1
UY - Uruguay 1
Totale 36.831
Città #
Fairfield 2.731
Chandler 2.288
Ashburn 2.185
Woodbridge 1.699
Houston 1.336
Wilmington 1.285
Ann Arbor 1.209
Singapore 1.134
Seattle 1.083
Cambridge 952
Jacksonville 809
Dublin 629
Medford 622
Des Moines 583
Palermo 449
Princeton 387
Nanjing 368
Altamura 357
Lawrence 269
New York 252
Dearborn 236
Tulsa 219
Boardman 205
San Diego 197
Santa Clara 195
Beijing 191
Milan 149
Abidjan 143
Nanchang 133
Krefeld 130
Brussels 125
Shenyang 120
Venice 117
Ludwigshafen am Rhein 112
Jinan 101
Munich 98
Hebei 97
Changsha 93
Rome 84
Jiaxing 78
Tianjin 78
Bremen 74
Kumar 68
San Mateo 65
San Paolo di Civitate 65
London 57
Columbus 52
Helsinki 52
Los Angeles 49
Tehran 49
Ningbo 48
Seongnam 48
Zhengzhou 45
Hong Kong 43
Verona 43
Düsseldorf 41
Falls Church 39
Saint Petersburg 39
Guangzhou 36
Redwood City 35
Naples 32
Florence 29
Bari 27
Orange 27
Norwalk 26
Taizhou 26
Chicago 25
Basel 24
Catania 23
Izmir 23
Kunming 23
Hangzhou 22
Rottweil 22
Napoli 21
Atlanta 20
Dallas 20
Turin 20
Washington 20
Lappeenranta 18
Pune 18
Amsterdam 17
Auburn Hills 17
Kilburn 17
Redmond 17
Shanghai 17
Bologna 16
Phoenix 16
Bergamo 15
Haikou 15
Hefei 15
Kraków 15
Moscow 15
Siena 15
Council Bluffs 14
Frankfurt am Main 13
Toronto 13
Trieste 12
Central 11
Groningen 11
Lanzhou 11
Totale 25.234
Nome #
L'ecocardiografia speckle tracking: Roadmap per la misurazione e l'utilizzo clinico 782
Effects of SGLT2 inhibitors on cardiac structure and function 461
Acidi grassi ematici e infarto miocardico 373
Cardiotoxic Effects of Anti-VEGFR Tyrosine Kinase Inhibitors 219
Pharmacological therapy in children with atrial fibrillation and atrial flutter 185
Impact of insulin resistance on cardiac and vascular function 184
Chronic pharmacological treatment in takotsubo cardiomyopathy 182
G-protein-coupled receptor kinase 5 polymorphism and Takotsubo cardiomyopathy. 181
Remodeled ostial atherosclerotic plaque in a single coronary artery demonstrated by computed tomography coronary angiography 174
Early detection of coronary artery flow and myocardial perfusion impairment in hypertensive patients evidenced by myocardial blush grade (MBG) and thrombolysis in myocardial infarction (TIMI) frame count (TFC). 169
Integrated non-invasive approach to atherosclerosis with cardiac CT and carotid ultrasound in patients with suspected coronary artery disease 169
Management of direct oral anticoagulants in patients with atrial fibrillation undergoing cardioversion 168
Sex differences in anthracycline-induced cardiotoxicity: the benefits of estrogens 166
Hsp60 and heme oxygenase-1 (Hsp32) in acute myocardial infarction 164
Anticoagulant drugs in noncompaction: a mandatory therapy? 161
The association between coronary microvascular dysfunction and carotid intima media thickness in patients with cardiac syndrome X 160
Soluble CD40L and cardiovascular risk in asymptomatic low-grade carotid stenosis 158
Pharmacological Treatment of Patients with Chronic Critical Limb Ischemia: L-Propionyl-Carnitine Enhances the Short-Term Effects of PGE-1 157
Left ventricular noncompaction presenting like a doublechambered left ventricle 156
Early Effects of Sacubitril/Valsartan on Exercise Tolerance in Patients with Heart Failure with Reduced Ejection Fraction 155
Asymptomatic carotid lesions add to cardiovascular risk prediction 154
What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment 154
A rare case of Prinzmetal angina 3 days after coronary artery stenting with a second-generation drug-eluting stent. 153
A cardiac fibroma in a 7 year-old asymptomatic girl admitted for ECG anomalies 150
Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study 149
The percutaneous treatment of Patent Foramen Ovale, an effective and safe therapeutic choice 147
Diagnosis and definition of biventricular non-compaction associated to Ebstein's anomaly 146
Characteristics of coronary microcirculatory function in patients with Takotsubo syndrome 145
Changes of arterial hemodynamics in patients with type 2 diabetes mellitus or impaired glucose tolerance 144
Preclinical carotid atherosclerosis enhances the global cardiovascular risk and increases the rate of cerebro- and cardiovascular events in a five-year follow-up 144
Transient mid-ventricular dyskinesia: a variant of Takotsubo syndrome 144
Risk factors for contrast induced nephropathy: a study among Italian patients. 144
Long-term outcome in patients with Takotsubo syndrome presenting with severely reduced left ventricular ejection fraction 144
Isolated left ventricular non-compaction: A larger part of submerged iceberg with criteria for diagnosis to the limits of standard 143
Influence of climatic variables on acute myocardial infarction hospital admissions 143
Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes. 143
Erectile dysfunction is associated with low total serum testosterone levels and impaired flow-mediated vasodilation in intermediate risk men according to the framingham risk score 143
Chronic stress and early recurrence of takotsubo cardiomyopathy: A clinical case 143
Long-term parameters of heart rate variability in patients with insulin-resistance 143
Angioplastica percutanea e stent nel trattamento delle lesioni steno-obliteranti della succlavia sinistra in sogetti conm furto coronarop e vertebro-succlaveare. 142
Assessment of no-reflow phenomenon by myocardial blush grade and pulsed wave tissue doppler imaging in patients with acute coronary syndrome 142
Cardiotoxicity mechanisms of the combination of BRAF-inhibitors and MEK-inhibitors 142
Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy 141
Dietary strategy for prevention and management of dyslipidemia: International guidelines 140
Fetuin-A is Associated to Serum Calcium and AHSG T256S Genotype but Not to Coronary Artery Calcification 140
Approccio diagnostico non invasivo con tomografia computerizzata multidetettore a 40 strati per lo studio della malattia aterosclerotica coronarica 139
Magnetic resonance in isolated noncompaction of the ventricular myocardium 139
ASSOCIATION OF ELEVATED FIBRINOGEN AND C-REACTIVE PROTEIN LEVELS WITH CAROTID LESIONS IN PATIENTS WITH NEWLY DIAGNOSED HYPERTENSION OR TYPE-II DIABETES 139
Neuromuscular disorders and non compaction: How much is the strength of the association and how can it be suspected? 138
Infective Endocarditis: Preliminary Results of a Cohort Study in the Southern Italian Population 138
Relationship between endothelial dysfunction, intima media thickness, hypertension and other cardiovascular risk factors in asymptomatic subjects 137
Early subclinical ventricular dysfunction in patients with insulin resistance 136
Angiographic Evaluation of Coronary Microvascular Dysfunction in Patients with Heart Failure and Preserved Ejection Fraction 136
Heart-type fatty acid binding protein is a sensitive biomarker for early AMI detection in troponin negative patients: a pilot study 136
From molecular mechanisms to clinical management of antineoplastic drug-induced cardiovascular toxicity: A translational overview 136
Effects of drug therapy on cardiac arrhythmias and ischemia in hypertensives with LVH. 135
Evaluation of diastolic function by the Tissue doppler in children affected by non- compaction 134
Asymptomatic carotid lesions and aging: role of hypertension and other traditional and emerging risk factors 134
Multiplane two-dimensional versus real time three-dimensional transesophageal echocardiography in ischemic mitral regurgitation 134
Left bundle branch block and myocardial infarction, a diagnosis not always easy: Our experience and review of literature 134
Native Mitral Valve Endocarditis Caused by Neisseria elongata subsp. nitroreducens in a Patient with Marfan Syndrome: First Case in Italy and Review of the Literature 134
The association between the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor-1 gene and extension of postsurgical calf vein thrombosis. 134
Prevalence and Prognostic Impact of Diabetes in Takotsubo Syndrome: Insights From the International, Multicenter GEIST Registry 133
Anticoagulant drugs in noncompaction: a mandatory therapy? 132
Modification of the lipidic and coagulative pattern in postmenopause women: effect of hormone replacement therapy. 132
Preclinical atherosclerosis and metabolic syndrome increase cardio- and cerebrovascular events rate: a 20-year follow up 132
Usefulness of regional right ventricular and right atrial strain for prediction of early and late right ventricular failure following a left ventricular assist device implant: A machine learning approach 132
Aterosclerosi Preclinica e Rischio Cardiovascolare Globale 131
Chemotherapy-induced cardiotoxicity: role of the conventional echocardiography and the Tissue Doppler 131
Percutaneous angioplasty and stenting of left subclavian artery lesions for the treatment of patients with concomitant vertebral and coronary subclavian steal syndrome. 130
Bicuspid aortic valve and unruptured sinus of Valsalva aneurysm, a rare association 130
Short-term Changes in Gal 3 Circulating Levels After Acute Myocardial Infarction 130
Asymptomatic ventricular pre-excitation in children 129
An uncommon case of syncope in a 4-year-old child affected by a long QT syndrome 129
[Cardiovascular risk profile of patients with psoriasis]. 129
DELAYED MRI HYPERENHANCEMENT IN NONCOMPACTION: SIGN OF FIBROSIS CORRELATED WITH CLINICAL SEVERITY 129
Multimodality imaging approach to paradoxical embolism: a cauliflower mass on the Eustachian valve 129
Optimal duration of treatment in surgical patients with calf venous thrombosis localized only in one or two leg. 127
Chronic inflammation: A key role in degeneration of bicuspid aortic valve 127
Unusual case of left ventricular pseudoaneurysm 126
Chemotherapy cardiotoxicity: cardioprotective drugs and early identification of cardiac dysfunction. 126
Atherosclerosis, degenerative aortic stenosis and statins 125
Scrotal swelling in a patient with paroxysmal supraventricular tachycardia 125
Fatal heart failure induced by pazopanib in a sarcoma patient previously treated with gemcitabine 124
Contrast-induced nephropathy after percutaneous coronary intervention in simple lesions: risk factors and incidence are affected by the definition utilized. 124
TASC II - DOCUMENTO DI CONSENSO INTERSOCIETARIO TRANSATLANTICO PER IL TRATTAMENTO DELLA MALATTIA VASCOLARE PERIFERICA 123
The role of statins in preventing the progression of congestive heart failure in patients with metabolic syndrome 123
Impact of moderate ischemic mitral regurgitation after isolated coronary artery bypass grafting 122
Atherosclerosis, inflammation and Chlamydia pneumoniae. 122
Helicobacter pylori and atrial fibrillation: absence of correlations 121
Troponin I/ejection fraction ratio: A new index to differentiate Takotsubo cardiomyopathy from myocardial infarction 121
Real-world use of ticagrelor and prasugrel in patients with NSTEMI undergoing percutaneous coronary intervention 121
Markers of inflammation are strong predictors of subclinical and clinical atherosclerosis in women with hypertension. 120
Post-myocarditis autonomic imbalance: A possible cause of arrhythmias? 119
The PFO anatomy evaluation as possible tool to stratify the associated risks and the benefits arising from the closure 119
Role of ARBs in the blood hypertension therapy and prevention of cardiovascular events 119
Relationship between epicardial fat and diastolic dysfunction in obese subjects: an echocardiographic study 119
Coronary microvascular dysfunction in patients with diabetes, hypertension and metabolic syndrome 119
Association between asymptomatic carotid atherosclerosis and degenerative aortic stenosis. 119
Enhanced external counterpulsation for treatment of refractory angina pectoris. 118
Totale 15.227
Categoria #
all - tutte 148.261
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 148.261


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.683 0 0 0 0 0 1.133 907 494 882 349 579 339
2020/20214.888 206 433 394 398 662 216 393 324 585 358 454 465
2021/20224.215 191 805 88 192 123 179 184 267 507 610 226 843
2022/20237.214 623 1.202 106 735 683 987 629 1.034 747 67 271 130
2023/20243.281 138 380 194 403 235 608 361 410 39 78 134 301
2024/20252.752 243 562 646 701 338 262 0 0 0 0 0 0
Totale 38.763